Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NxStage Medical Inc gives Q1 2014 revenue guidance above analysts' estimates; gives FY 2014 guidance; gives Q1, FY 2014 earnings guidance below analysts' estimates - Conference Call


Thursday, 27 Feb 2014 07:31am EST 

NxStage Medical Inc:Expects Q1 2014 revenue to be in the range of $69.5-$70.5 mln.Expects Q1 2014 net loss in the range of $6.5-$7.5 mln.Expects Q1 2014 earnings per share (EPS) in the range of $(0.11)-$(0.12).Forecasts FY 2014 revenue to be between $283-$288 mln.Expects FY 2014 net loss in the range of $23-$27 mln.Expects FY 2014 EPS)in the range of $(0.37)-$(0.44).Q1 2014 revenue of $68.6 mln, net income of $(5.69) mln and EPS of $(0.09) - Thomson Reuters I/B/E/S.FY 2014 revenue of $286.71 mln, net income of $(17.55) mln and EPS of $(0.28) - Thomson Reuters I/B/E/S. 

Company Quote

14.78
0.16 +1.09%
10:33am EDT